(1)
Prediction the Results of Ablative Treatment in Patients With Uveal Melanoma Using Molecular Markers of Lymphocyte Activation. Ukr. j. ophthalmol. 2026, No. 2, 44-48. https://doi.org/10.31288/oftalmolzh201524448.